Arlington Capital Management, Inc. Moderna, Inc. Transaction History

Arlington Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $9,311 - $15,328	-92 Reduced 4.49%	1,958 $232,000
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $4,518 - $6,787	-65 Reduced 3.07%	2,050 $203,000
Q3 2023 Oct 24, 2023	BUY	$96.41 - $126.61 $203,907 - $267,780	2,115 New	2,115 $218,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Arlington Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Arlington Capital Management, Inc. with notifications on news.